We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Lower Premiums Affect Cigna's Q3 Earnings? Key Insights Here
Read MoreHide Full Article
Key Takeaways
Cigna will report Q3 2025 results on Oct. 30, with EPS estimated at $7.70 on $67.16B in revenues.
Evernorth revenues are projected to rise 9%, while pharmacy and fee income show double-digit growth.
Premiums and medical customers are expected to decline, with margins pressured by higher costs.
Global health insurance company The Cigna Group (CI - Free Report) is set to report third-quarter 2025 results on Oct. 30, 2025, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $7.70 per shareon revenues of $67.16 billion.
The third-quarter earnings estimate increased by a penny over the past 60 days. The bottom-line projection indicates a year-over-year increase of 2.5%. Also, the Zacks Consensus Estimate for quarterly revenues suggests year-over-year growth of 5.4%.
Image Source: Zacks Investment Research
For full-year 2025, the Zacks Consensus Estimate for Cigna’s revenues is pegged at $267.39 billion, implying an increase of 8.2% year over year. Also, the consensus mark for 2025 EPS is pegged at $29.69, signaling growth of 8.6%, year over year.
Cignabeat the earnings estimates in three of the last four quarters and missed once, with the average surprise being negative 1.2%. This is depicted in the figure below.
Our proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That’s not the case here.
CI has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
The Zacks Consensus Estimate for pharmacy revenues indicates a 10.1% improvement from the prior-year quarter’s number. Also, the consensus estimate for fees and other revenues signals 10.3% year-over-year growth. The Zacks Consensus Estimate for net investment income suggests nearly 190% year-over-year growth.
The consensus mark for revenues from the overall Evernorth Health Services segment is pegged at $57.2 billion, indicating 9% growth from the prior-year quarter’s figure. The consensus estimate for pre-tax adjusted income from Evernorth indicates a 0.3% increase from a year ago.
However, the consensus mark for premiums implies a 21.1% decrease from the year-ago quarter. The consensus mark for Cigna’s total medical customers is pegged at 18.1 million, indicating a decline from 19 million a year ago.
The Zacks Consensus Estimate for Cigna Healthcare revenues suggests a 17.9% decrease. The consensus estimate for pre-tax adjusted income from Cigna Healthcare indicates a 13.7% decline from a year ago.
Its margins are expected to have been impacted by higher pharmacy and other service costs. The consensus mark for the medical care ratio or MCR is pegged at 84.15%, up from 82.80% a year ago, partially offsetting the positives.
How Did Cigna’s Peers Perform?
Several healthcare companies, including UnitedHealth Group Incorporated (UNH - Free Report) , Molina Healthcare, Inc. (MOH - Free Report) and Elevance Health, Inc. (ELV - Free Report) , have already reported their financial results for the September quarter of 2025. Here’s how they had performed:
UnitedHealth reported third-quarter 2025 adjusted EPS of $2.92, which beat the Zacks Consensus Estimate of $2.75. However, the bottom line declined 59.2% year over year. The quarterly earnings were aided by growth in domestic commercial membership and strength witnessed in Optum Rx. However, UnitedHealth’s elevated medical costs partially offset the positives.
Molina Healthcare reported third-quarter 2025 adjusted EPS of $1.84, which missed the Zacks Consensus Estimate of $3.97. Also, the bottom line fell 69.4% from the year-ago period. The results were affected by higher medical care costs and general and administrative expenses. However, Molina Healthcare’s rising premiums and rate hikes partially offset the negatives.
Elevance Health reported third-quarter 2025 adjusted EPS of $6.03, which surpassed the Zacks Consensus Estimate by 21.1%. But the bottom line dropped 29.9% year over year. The results benefited from strong growth in premiums, product revenues and net investment income. However, the upside was partly offset by a decline in Elevance Health’s overall medical membership and an elevated expense level.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Will Lower Premiums Affect Cigna's Q3 Earnings? Key Insights Here
Key Takeaways
Global health insurance company The Cigna Group (CI - Free Report) is set to report third-quarter 2025 results on Oct. 30, 2025, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $7.70 per shareon revenues of $67.16 billion.
The third-quarter earnings estimate increased by a penny over the past 60 days. The bottom-line projection indicates a year-over-year increase of 2.5%. Also, the Zacks Consensus Estimate for quarterly revenues suggests year-over-year growth of 5.4%.
For full-year 2025, the Zacks Consensus Estimate for Cigna’s revenues is pegged at $267.39 billion, implying an increase of 8.2% year over year. Also, the consensus mark for 2025 EPS is pegged at $29.69, signaling growth of 8.6%, year over year.
Cignabeat the earnings estimates in three of the last four quarters and missed once, with the average surprise being negative 1.2%. This is depicted in the figure below.
Cigna Group Price and EPS Surprise
Cigna Group price-eps-surprise | Cigna Group Quote
Q3 Earnings Whispers for Cigna
Our proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That’s not the case here.
CI has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
You can see the complete list of today’s Zacks #1 Rank stocks here.
What’s Shaping Cigna’s Q3 Results?
The Zacks Consensus Estimate for pharmacy revenues indicates a 10.1% improvement from the prior-year quarter’s number. Also, the consensus estimate for fees and other revenues signals 10.3% year-over-year growth. The Zacks Consensus Estimate for net investment income suggests nearly 190% year-over-year growth.
The consensus mark for revenues from the overall Evernorth Health Services segment is pegged at $57.2 billion, indicating 9% growth from the prior-year quarter’s figure. The consensus estimate for pre-tax adjusted income from Evernorth indicates a 0.3% increase from a year ago.
However, the consensus mark for premiums implies a 21.1% decrease from the year-ago quarter. The consensus mark for Cigna’s total medical customers is pegged at 18.1 million, indicating a decline from 19 million a year ago.
The Zacks Consensus Estimate for Cigna Healthcare revenues suggests a 17.9% decrease. The consensus estimate for pre-tax adjusted income from Cigna Healthcare indicates a 13.7% decline from a year ago.
Its margins are expected to have been impacted by higher pharmacy and other service costs. The consensus mark for the medical care ratio or MCR is pegged at 84.15%, up from 82.80% a year ago, partially offsetting the positives.
How Did Cigna’s Peers Perform?
Several healthcare companies, including UnitedHealth Group Incorporated (UNH - Free Report) , Molina Healthcare, Inc. (MOH - Free Report) and Elevance Health, Inc. (ELV - Free Report) , have already reported their financial results for the September quarter of 2025. Here’s how they had performed:
UnitedHealth reported third-quarter 2025 adjusted EPS of $2.92, which beat the Zacks Consensus Estimate of $2.75. However, the bottom line declined 59.2% year over year. The quarterly earnings were aided by growth in domestic commercial membership and strength witnessed in Optum Rx. However, UnitedHealth’s elevated medical costs partially offset the positives.
Molina Healthcare reported third-quarter 2025 adjusted EPS of $1.84, which missed the Zacks Consensus Estimate of $3.97. Also, the bottom line fell 69.4% from the year-ago period. The results were affected by higher medical care costs and general and administrative expenses. However, Molina Healthcare’s rising premiums and rate hikes partially offset the negatives.
Elevance Health reported third-quarter 2025 adjusted EPS of $6.03, which surpassed the Zacks Consensus Estimate by 21.1%. But the bottom line dropped 29.9% year over year. The results benefited from strong growth in premiums, product revenues and net investment income. However, the upside was partly offset by a decline in Elevance Health’s overall medical membership and an elevated expense level.